Invitrogen™ Human JMJD6 Synthetic Peptide

Ref.: BL-RE-176527Manufacturer ref.: PEP-0922 50 μg
€149.00 excl. VAT

JMJD6 Synthetic Peptide, PEP-0922, from Invitrogen.

Gene ID (Enter)
23210
Species
Human
Purification method
Purified
Accession number
Q6NYC1
Common name
Human JMJD6
Brand
Invitrogen

JMJD6 Synthetic Peptide, PEP-0922, from Invitrogen.

JMJD6 Synthetic Peptide, PEP-0922, from Invitrogen.

This gene encodes a nuclear protein with a JmjC domain. JmjC domain-containing proteins are predicted to function as protein hydroxylases or histone demethylases. This protein was first identified as a putative phosphatidylserine receptor involved in phagocytosis of apoptotic cells; however, subsequent studies have indicated that it does not directly function in the clearance of apoptotic cells, and questioned whether it is a true phosphatidylserine receptor. Multiple transcript variants encoding different isoforms have been found for this gene.

Species

Species: Human.

Conservation

Storage: -20°C.

Formulation

Concentration: 200 μg/mL.

Regulatory status

Research only (RUO).

Packaging

Packaging: 50 μg.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)15399160
Specifications
Gene ID (Enter)23210
SpeciesHuman
Purification methodPurified
Accession numberQ6NYC1
Common nameHuman JMJD6
Concentration200 μg/mL
DescriptionSynthetic Peptide
FormatLiquid
FormulaPBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
For use with (application)Blocking Assay, Control
Gene symbol(s)JMJD6
LyophilizedNo
Product typePeptide
Quantity50 μg
Regulatory statusRUO - research use only
Storage and shipping
Content and storage-20°C
Conservative0.02% sodium azide
Storage stampPBS

Origin and customs

Manufacturer ref.PEP-0922
Country of originUnited States
HS customs code3824 99 92 00
A question or a specific configuration?
Contact us for a quote.